Navigation Links
ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)
Date:12/4/2008

ainties, as described at Section 4.2 "Facteurs de risque" (Risk Factors) of the Document de Base available on ExonHit Therapeutics' website (http://www.exonhit.com), that may cause actual results, performance or events to differ materially from those anticipated in the summary information.

In addition, ExonHit Therapeutics, its shareholders, and its affiliates, directors, officers, advisors and employees have not verified the accuracy of, and make no representations or warranties in relation to, statistical data or predictions contained in this press release that were taken or derived from third party sources or industry publications, and such statistical data and predictions are used in this press release for information purposes only.

Finally, this press release may be drafted in the French and English languages. In an event of differences between the texts, the French language version shall prevail.


'/>"/>
SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies
2. Loic Maurel Joins Exonhit Therapeutics to Become CEO
3. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
4. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
5. ExonHit Appoints a New Management Board
6. ExonHit Therapeutics - 2007 Financial Results
7. ExonHit Builds A New Organisation
8. ExonHit and bioMerieux Amend Their Strategic Partnership
9. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
10. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
11. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2014 /CNW/ - Canada,s Research-Based Pharmaceutical ... newly released report on Cost Drivers of Public Drug Plans ... to the report, the rates of change in drug costs ... of -0.8 percent in 2012/13 for a number of select ... examines the costs of medicines without considering their overall impact ...
(Date:4/1/2015)... Angeles, CA (PRWEB) April 01, 2015 ... reader that can read both chromatographic and fluorescent rapid ... leading supplier of high performance, quantitative readers and is ... globally. The HRDR-400 is a first of its kind ... in one instrument. , Dr. Neven Karlovac, CEO ...
(Date:4/1/2015)... 01, 2015 National recruitment firm ... of Brad Allen as Head of Sales at Optimal ... system market. , Allen brings over 20 years ... at a number of companies including Dell Services Healthcare, ... experience were a perfect fit for accomplishing the goals ...
(Date:3/31/2015)... Eastern Kentucky University is ranked ... of criminal justice degree programs by Nonprofitcollegesonline.com. , ... ideas and high quality educational opportunities,” Editor Liz ... We are confident that students will find both ... the site’s first “Students before Profits” list, and ...
Breaking Biology Technology:Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2Slone Partners Fills Head of Sales at Optimal Medicine 2EKU Ranked in Top 50 Among Online Criminal Justice Degrees 2
... May 18 Dr. Jonathan M. Rothberg , chairman, CEO ... winner of the Connecticut Medal of Technology for his development of innovative genomic ... Dr. Rothberg is the founder ... has dedicated his life to developing sequencing technology that will help improve the ...
... , ... wastes has never been easier, or less smelly, thanks to a new indoor composting ... composting bucket collects food scraps in an airtight bucket. Bokashi, made using SCD,s probiotic ... , ...
... SANTA BARBARA, Calif. , May 17 Abviva, ... development and commercialization of breast cancer related applications of Mammastatin, ... on the core technology that may be used for therapeutic ... the Mammastatin Serum Assay (MSA). The patents are the most ...
Cached Biology Technology:Genetics Entrepreneur Jonathan Rothberg Wins CT Medal of Technology 2All Seasons Indoor Composter™ and All Seasons Bokashi™ Provide Easy Way to Recycle Food Waste Right in Your Kitchen 2All Seasons Indoor Composter™ and All Seasons Bokashi™ Provide Easy Way to Recycle Food Waste Right in Your Kitchen 3Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics 2Abviva Announces Further Patent Issuance for Technology Used in Breast Cancer Diagnostics and Therapeutics 3
(Date:3/12/2015)... , March 12, 2015 ... a standardized identity and access management (IAM) solution ... implementation schedule. With Beta System,s new IAM package, ... best practices gleaned from multiple IAM implementations across ... the software as well as any necessary services ...
(Date:3/11/2015)... 11, 2015   The Sync Project™ ... scientifically measure and harness music to improve health. ... and objective measurements of physiology, enabling the study ... in large populations. It is designed for medical ... perform rigorous studies and accelerate the discovery of ...
(Date:3/10/2015)... 10, 2015   Tute Genomics , pioneer in ... by next-generation sequencing company PrimBio Research Institute ... targeted gene panel interpretation. PrimBio, a certified ... most current technologies to support the work of experts ... offers two types of exome sequencing services: 1) Targeted ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... GAINESVILLE, Fla. You might not know what it,s ... especially after an accident, it is likely you have ... a patient,s throat to prevent regurgitation and spilling of ... is being administered. Such regurgitation could result in ...
... Two experimental treatments, a retinal prosthesis and fetal tissue ... diseases. The findings, presented at Neuroscience 2009, the annual ... largest source of emerging news on brain science and ... Researchers also reported that an engineered protein restored vision ...
... 2009 New research focused on the quality ... as increasingly popular botanicals is being sponsored by ... Fellowship Program. USP fellowships are awarded to graduate ... care/scientific doctoral or post-doctoral programs to support research ...
Cached Biology News:UF scientists discover new explanation for controversial old patient-care technique 2UF scientists discover new explanation for controversial old patient-care technique 3Experimental treatments restore partial vision to blind people 2New research examining essential drugs, emerging botanicals supported by USP Awards 2New research examining essential drugs, emerging botanicals supported by USP Awards 3
Request Info...
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Applications: Epitope mapping, Mapping protein-protein contacts, Identification of enzyme substrates/inhibitors, Identification of receptor agonists/antagonists...
Biology Products: